Blog

According to top doctors, not all dementia patients would benefit. “Donanemab is best suited for early symptomatic Alzheimer’s disease, mild cognitive impairment due to Alzheimer’s, mild Alzheimer’s dementia, Amyloid-positive patients and is not meant for advanced or severe dementia,” Dr. Sudhir Kumar, neurologist from Apollo Hospital, Hyderabad, wrote on X.